Biotech entity
pharma is the sole category represented across all 1 tracked stories. Roivant Sciences is most often covered alongside Arbutus Biopharma, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Roivant Sciences, all published on March 4, 2026.
Last mentioned: Mar 4, 2026
Entity pulse
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
pharma is the sole category represented across all 1 tracked stories. Roivant Sciences is most often covered alongside Arbutus Biopharma, which appears in 1 of these 1 story. We currently track 1 Biotech story that mention Roivant Sciences, all published on March 4, 2026. Each carries 2 original sources on average.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 16 Biotech stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Roivant Sciences. Shared-story counts are live from our verified record — not editorial picks.
Settlement Reached
Moderna agrees to pay up to $2.25 billion to resolve all outstanding claims.
Claims Construction
Court rulings on patent definitions provide momentum for the plaintiffs.
Lawsuit Filed
Arbutus and Genevant sue Moderna for patent infringement in Delaware federal court.
Vaccine Launch
Moderna receives EUA for Spikevax, utilizing LNP technology for delivery.
Moderna has reached a landmark $2.25 billion settlement with Roivant Sciences and Arbutus Biopharma to resolve long-standing patent disputes over lipid nanoparticle technology used in its COVID-19 vaccine. The agreement provides a massive capital infusion for Roivant while removing a significant legal overhang for Moderna's future mRNA pipeline.
Roivant Sciences is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
